A strategy of antigen incorporation into exosomes: Comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles
- 26 November 2012
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 30 (50), 7229-7237
- https://doi.org/10.1016/j.vaccine.2012.10.010
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Rome, Italy
This publication has 36 references indexed in Scilit:
- EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells—A New Option for the Treatment of B-CLLPLOS ONE, 2011
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesiclesCellular and Molecular Life Sciences, 2011
- Exosomes: immune properties and potential clinical implementationsSeminars in Immunopathology, 2010
- Exosomes: Extracellular organelles important in intercellular communicationJournal of Proteomics, 2010
- Glycosyl-Phosphatidylinositol-Anchored Interleukin-2 Expressed on Tumor-Derived Exosomes Induces Antitumor Immune Response in VitroTumori Journal, 2010
- Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activityNature, 2009
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkersNature, 2008
- Exosome Display technology: Applications to the development of new diagnostics and therapeuticsBlood Cells, Molecules, and Diseases, 2005
- A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancerJournal of Translational Medicine, 2005
- Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trialJournal of Translational Medicine, 2005